Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · IEX Real-Time Price · USD
23.87
+0.08 (0.34%)
Jul 22, 2024, 10:17 AM EDT - Market open
ARCT Employees
Arcturus Therapeutics Holdings had 180 employees as of December 31, 2023. The number of employees increased by 10 or 5.88% compared to the previous year.
Employees
180
Change (1Y)
10
Growth (1Y)
5.88%
Revenue / Employee
$691,811
Profits / Employee
-$596,089
Market Cap
639.09M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Pediatrix Medical Group | 5,450 |
PetIQ | 1,933 |
Fulgent Genetics | 1,184 |
Exscientia | 483 |
Phathom Pharmaceuticals | 452 |
Prime Medicine | 234 |
IGM Biosciences | 224 |
UroGen Pharma | 201 |
ARCT News
- 3 days ago - Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on August 5, 2024 - Business Wire
- 20 days ago - Arcturus Therapeutics Provides Updates for Ornithine Transcarbamylase (OTC) Deficiency and Cystic Fibrosis (CF) Programs - Business Wire
- 4 weeks ago - Arcturus Therapeutics Appoints Moncef Slaoui, Ph.D., to Board of Directors - Business Wire
- 6 weeks ago - Arcturus Therapeutics Presents New Clinical Data at 47th Annual European Cystic Fibrosis Conference - Business Wire
- 7 weeks ago - Arcturus Therapeutics Announces Positive Development for Cystic Fibrosis Program - Business Wire
- 2 months ago - Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine - Business Wire
- 2 months ago - Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences - Business Wire
- 2 months ago - Arcturus Therapeutics Announces First Quarter 2024 Financial Update and Pipeline Progress - Business Wire